Real Heart: Realheart strengthens R&D Team with three engineers

2021-06-14 08:30:00

Oliver Chu, who joins the company's Mechanical Design team, has over ten years of international experience in the design of medical devices, including Class III products, as well as fluid handling pumps. He joins the company from Essity in Gothenburg, where he was Mechanical Lead. He is a graduate of the Georgia Institute of Technology in Atlanta, USA, and the inventor on five patent applications for medical device solutions. He is fluent in Mandarin and well-connected in Asia, further strengthening the company's international network.

Daniel Jonasson is recruited from the consulting company Sigma Technology Consulting as Systems Developer and will, among other things, work with the development of the smart control unit. Daniel's professional experience includes military service as a CBRN officer for crisis management in chemical, biological, and radio nuclear disasters, and SAAB surveillance where he worked closely with the Armed Forces with communications links. His expertise is in Artificial Intelligence and robotics, both relevant skills for the development of Realheart's product portfolio.

Soteris Andreou, who will graduate from Cardiff University in Wales with top grades shortly, will work closely with the company's other engineers in both in vitro testing and mechanical design, including supporting the team with various types of bench testing of prototypes. Soteris also has medical device experience, having worked on the development of innovative electrosurgical products as an Undergraduate Engineer at Olympus (OSTE).

`'I am excited to have been able to make these recruitments according to our plan. Before the end of the year, we will have doubled the number of engineers employed, with some bringing in completely new skills and others replacing consultants. Working with consultants has given us a level of flexibility but is costly and now we want to build our organisation with our own loyal and highly motivated employees to drive the business forward with even greater vigour. At the same time, we are constantly reviewing our organisation for opportunities to improve efficiency" said Ina Laura Perkins, CEO.

For more information please contact:
Ina Laura Perkins, CEO, at +46(0)70 406 49 21 or inalaura.perkins@realheart.se

Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart TAH has a unique, patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atriums and two chambers) which provides the opportunity to generate a physiologically adapted blood flow that mimics the body's natural circulation. A unique concept in the medical technology world.

Cision